- Home
- AZTA vs ARWR Comparison
AZTA vs ARWR Comparison
Compare AZTA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- ARWR
- Stock Information
- Founded
- AZTA 1978
- ARWR 2003
- Country
- AZTA United States
- ARWR United States
- Employees
- AZTA N/A
- ARWR N/A
- Industry
- AZTA Industrial Machinery/Components
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- AZTA Technology
- ARWR Health Care
- Exchange
- AZTA Nasdaq
- ARWR Nasdaq
- Market Cap
- AZTA 1.8B
- ARWR 1.8B
- IPO Year
- AZTA 1995
- ARWR 1993
- Fundamental
- Price
- AZTA $26.77
- ARWR $13.03
- Analyst Decision
- AZTA Buy
- ARWR Buy
- Analyst Count
- AZTA 3
- ARWR 11
- Target Price
- AZTA $50.67
- ARWR $41.44
- AVG Volume (30 Days)
- AZTA 979.4K
- ARWR 1.6M
- Earning Date
- AZTA 05-07-2025
- ARWR 05-12-2025
- Dividend Yield
- AZTA N/A
- ARWR N/A
- EPS Growth
- AZTA N/A
- ARWR N/A
- EPS
- AZTA N/A
- ARWR N/A
- Revenue
- AZTA $669,171,000.00
- ARWR $2,500,000.00
- Revenue This Year
- AZTA N/A
- ARWR $4,380.43
- Revenue Next Year
- AZTA $5.38
- ARWR $64.24
- P/E Ratio
- AZTA N/A
- ARWR N/A
- Revenue Growth
- AZTA 4.70
- ARWR N/A
- 52 Week Low
- AZTA $24.06
- ARWR $9.57
- 52 Week High
- AZTA $63.58
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- AZTA 43.19
- ARWR 47.38
- Support Level
- AZTA $23.91
- ARWR $12.44
- Resistance Level
- AZTA $27.06
- ARWR $14.97
- Average True Range (ATR)
- AZTA 1.41
- ARWR 0.74
- MACD
- AZTA 0.57
- ARWR 0.11
- Stochastic Oscillator
- AZTA 67.14
- ARWR 37.01
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.